Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (451-460 of 588) with videos related to

Pageof 59
Sort By:
Mayo Clinic Proceedings|September 6, 2016
New Insulin Delivery RecommendationsAnders H Frid, Gillian Kreugel, Giorgio Grassi, et al.
Journal of Diabetes|December 10, 2020
Genetic variants of ABCC8 and phenotypic features in Chinese early onset diabetesMeng Li, Siqian Gong, Xueyao Han, et al.
Diabetes, Obesity & Metabolism|March 12, 2023
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER studyBrenda Bongaerts, Oliver Kuss, Fabrice Bonnet, et al.
Diabetes/Metabolism Research and Reviews|March 28, 2024
Overburden of rare ALMS1 deleterious variants in Chinese early-onset type 2 diabetes with severe insulin resistanceSimin Zhang, Siqian Gong, Meng Li, et al.
Diabetes/Metabolism Research and Reviews|November 19, 2022
Distribution of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8 in type 1 diabetes and latent autoimmune diabetes: A nationwide, multicentre, cross-sectional studyWenqi Fan, Xixi Nan, Yiman Peng, et al.
Diabetes Care|October 25, 2023
Rare Variant in Metallothionein 1E Increases the Risk of Type 2 Diabetes in a Chinese PopulationXiantong Zou, Mengdie Hu, Xiuting Huang, et al.
Diabetes, Obesity & Metabolism|November 6, 2020
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendationsChin Meng Khoo, Chaicharn Deerochanawong, Siew Pheng Chan, et al.
Journal of Diabetes Investigation|November 21, 2025
Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 studyLeili Gao, Zhifeng Cheng, Guoqing Ma, et al.
Diabetes, Obesity & Metabolism|January 21, 2017
Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in ChinaLinong Ji, Puhong Zhang, Dongshan Zhu, et al.
BMJ Open|September 2, 2020
Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programmeKamlesh Khunti, Marilia B Gomes, Mikhail Kosiborod, et al.
Pageof 59

Showing results (451-460 of 588) with videos related to

Sort By:
Pageof 59
Mayo Clinic Proceedings|September 6, 2016
New Insulin Delivery RecommendationsAnders H Frid, Gillian Kreugel, Giorgio Grassi, et al.
Journal of Diabetes|December 10, 2020
Genetic variants of ABCC8 and phenotypic features in Chinese early onset diabetesMeng Li, Siqian Gong, Xueyao Han, et al.
Diabetes, Obesity & Metabolism|March 12, 2023
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER studyBrenda Bongaerts, Oliver Kuss, Fabrice Bonnet, et al.
Diabetes/Metabolism Research and Reviews|March 28, 2024
Overburden of rare ALMS1 deleterious variants in Chinese early-onset type 2 diabetes with severe insulin resistanceSimin Zhang, Siqian Gong, Meng Li, et al.
Diabetes/Metabolism Research and Reviews|November 19, 2022
Distribution of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8 in type 1 diabetes and latent autoimmune diabetes: A nationwide, multicentre, cross-sectional studyWenqi Fan, Xixi Nan, Yiman Peng, et al.
Diabetes Care|October 25, 2023
Rare Variant in Metallothionein 1E Increases the Risk of Type 2 Diabetes in a Chinese PopulationXiantong Zou, Mengdie Hu, Xiuting Huang, et al.
Diabetes, Obesity & Metabolism|November 6, 2020
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendationsChin Meng Khoo, Chaicharn Deerochanawong, Siew Pheng Chan, et al.
Journal of Diabetes Investigation|November 21, 2025
Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 studyLeili Gao, Zhifeng Cheng, Guoqing Ma, et al.
Diabetes, Obesity & Metabolism|January 21, 2017
Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in ChinaLinong Ji, Puhong Zhang, Dongshan Zhu, et al.
BMJ Open|September 2, 2020
Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programmeKamlesh Khunti, Marilia B Gomes, Mikhail Kosiborod, et al.
Pageof 59